(19)

(11)

EP 4 423 764 A1

(12)

(43) Date of publication: 04.09.2024 Bulletin 2024/36 (21) Application number: 22887659.5 (22) Date of filing: 27.10.2022

(51) International Patent Classification (IPC):  G16H 20/30(2018.01) G16H 50/20(2018.01) G16H 50/30(2018.01) G16H 40/63(2018.01) (52) Cooperative Patent Classification (CPC): G16H 50/30; G16H 50/20; G16H 20/30; G16H 40/63; Y02A 90/10; Y02A 50/30; G16H 20/70 (86) International application number: PCT/KR2022/016607 (87) International publication number: WO 2023/075464 (04.05.2023 Gazette 2023/18)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 27.10.2021 US 202117512579 (71) Applicant: S-Alpha Therapeutics, Inc. Seoul 06628 (KR)	(72) Inventors: CHOI, Seung Eun Seoul 06628 (KR) LEE, Yong Sun Princeton,, New Jersey 08540 (US) HAHM, Ja Rang Seoul 06628 (KR) (74) Representative: Beck Greener LLP  Fulwood House 12 Fulwood Place London WC1V 6HR London WC1V 6HR (GB)